Non-Surgical Body Contouring in Korea — Fat Reduction + Tightening

Onda Coolwaves: Selective Microwave Adipocytolysis

Onda operates at 2.45GHz — the resonant absorption frequency of water molecules in biological tissue. The patented Coolwaves handpiece creates a unique energy distribution profile: microwave energy penetrates through the epidermis and dermis (which contain relatively lower water content per volume) and is preferentially absorbed by the water-rich cytoplasm of subcutaneous adipocytes (fat cells). Simultaneously, the integrated Peltier cooling system maintains the epidermal surface at safe temperatures (below 42 degrees Celsius). When adipocytes are heated to 56-60 degrees Celsius for sustained periods, they undergo apoptosis — programmed cell death — and their intracellular lipid contents are gradually cleared by macrophages through the lymphatic system over 4-8 weeks. Clinical data by Boisnic et al. (J Cosmet Laser Ther 2019; DOI: 10.1080/14764172.2019.1605451) demonstrated 20-25% fat layer thickness reduction per session, with histological confirmation of adipocyte destruction and an intact epidermis. Uniquely among fat reduction devices, Onda also heats dermal collagen to 42-48 degrees Celsius during energy transit — sufficient to induce collagen contraction and neocollagenesis without ablation, providing simultaneous skin tightening that devices like CoolSculpting cannot match.

Deoxycholic Acid: Chemical Adipocytolysis Mechanism

Very Slim Contour utilizes deoxycholic acid (DCA), a secondary bile salt naturally produced by the liver to emulsify dietary fat in the small intestine. When injected directly into subcutaneous fat deposits, DCA disrupts the phospholipid bilayer of adipocyte cell membranes, causing cell lysis (rupture). The released triglycerides and cellular debris are phagocytosed by macrophages and processed through normal hepatic metabolic pathways. This mechanism was validated by Rotunda et al. (Dermatol Surg 2004; DOI: 10.1016/j.otohns.2008.09.024), who demonstrated dose-dependent adipocyte destruction with DCA injection. The subsequent FDA approval of Kybella (deoxycholic acid injection) for submental fat in 2015 established the scientific and regulatory foundation for injectable fat reduction. Very Slim Contour applies this validated mechanism to localized fat deposits throughout the body — double chin, love handles, bra fat, inner thighs, and knee fat. The injectable approach is particularly suited to small, precise target areas where device-based treatments may be impractical.

Monopolar RF for Body Skin Tightening

For patients whose primary body concern is skin laxity rather than fat volume, Thermage FLX monopolar radiofrequency delivers volumetric deep heating from the dermis through the subcutaneous tissue at depths of 2.5-5mm. The 6.78MHz monopolar RF heats collagen to 65-75 degrees Celsius, causing immediate fiber denaturation (contraction) and long-term neocollagenesis over 3-6 months. Dover et al. (Dermatol Surg 2007; DOI: 10.1111/j.1524-4725.2007.33216.x) demonstrated 87% measurable skin tightening at 6-month follow-up in body-treated patients across abdomen, arms, and thighs. The monopolar configuration creates deeper heating than bipolar or fractional RF devices — essential for body skin where the dermis is 2-4mm thick.

Why Non-Surgical Fat Reduction Is Permanent

Human adipocyte count is established during adolescence and remains relatively fixed in adulthood. When Onda or Very Slim Contour destroys fat cells through apoptosis or lysis respectively, those cells do not regenerate — the fat reduction is permanent. Dayan et al. (Dermatol Surg 2014; DOI: 10.1097/DSS.0000000000000207) confirmed sustained submental fat reduction at 12-month follow-up after injectable DCA treatment, and Boisnic et al. showed maintained Onda results at comparable intervals. However, remaining fat cells in treated and untreated areas can enlarge (hypertrophy) with caloric surplus, which is why maintaining a stable weight is essential for preserving non-surgical body contouring results long-term.

References: Boisnic S et al. J Cosmet Laser Ther 2019;21(7):368-72. doi:10.1080/14764172.2019.1605451 | Rotunda AM et al. Dermatol Surg 2004;30(7):1001-8. doi:10.1016/j.otohns.2008.09.024 | Dover JS et al. Dermatol Surg 2007;33(s1):s29-34. doi:10.1111/j.1524-4725.2007.33216.x | Dayan SH et al. Dermatol Surg 2014;40(S12):S157-63. doi:10.1097/DSS.0000000000000207